62
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Triggering Receptor Expressed on Myeloid Cells 2 Mediates the Involvement of M2-Type Macrophages in Pulmonary Tuberculosis Infection

, , , , , , , , & ORCID Icon show all
Pages 1919-1928 | Received 15 Sep 2023, Accepted 14 Mar 2024, Published online: 26 Mar 2024

References

  • Cobelens F, Suri R, Helinski M, et al. Accelerating research and development of new vaccines against tuberculosis: a global roadmap. Lancet Infect Dis. 2022;22(4):e108–e120. doi:10.1016/S1473-3099(21)00810-0
  • Sarınoğlu R C, Sili U, Eryuksel E, Olgun Yildizeli S, Cimsit C, Karahasan Yagci A. Tuberculosis and COVID-19: an overlapping situation during pandemic. J Infect Dev Ctries. 2020;14(7):721–725. doi:10.3855/jidc.13152
  • Wang Y, Zhu W, Li T, Chen W, Wang W. Changes in newly notified cases and control of tuberculosis in China: time-series analysis of surveillance data. Infect Diseases Poverty. 2021;10(1):16. doi:10.1186/s40249-021-00806-7
  • Khan A, Singh V, Hunter R, CJJolb J. Macrophage heterogeneity and plasticity in tuberculosis. J Leukoc Biol. 2019;106(2):275–282. doi:10.1002/JLB.MR0318-095RR
  • Albors-Vaquer A, Rizvi A, Matzapetakis M, et al. Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers. Emerging Microbes. 2020;9(1):1131–1139. doi:10.1080/22221751.2020.1760734
  • Ahmad F, Rani A, Alam A, et al. Macrophage: a cell with many faces and functions in tuberculosis. Front Immunol. 2022;13:747799. doi:10.3389/fimmu.2022.747799
  • Guirado E, Schlesinger L, Kaplan G. Macrophages in tuberculosis: friend or foe. Semin Immunopathol. 2013;35(5):563–583. doi:10.1007/s00281-013-0388-2
  • Tardito S, Martinelli G, Soldano S, et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmunity Rev. 2019;18(11):102397. doi:10.1016/j.autrev.2019.102397
  • Marino S, Cilfone N, Mattila J, et al. Macrophage polarization drives granuloma outcome during mycobacterium tuberculosis infection. Infection. 2015;83(1):324–338.
  • Refai A, Gritli S, Barbouche M, Essafi M. Mycobacterium tuberculosis virulent factor esat-6 drives macrophage differentiation toward the pro-inflammatory M1 phenotype and subsequently switches it to the anti-inflammatory M2 phenotype. Front Cell Infect Microbiol. 2018;8:327. doi:10.3389/fcimb.2018.00327
  • Wang L, Chen Q, Yu Q, Xiao J, Zhao H. Cigarette smoke extract-treated airway epithelial cells-derived exosomes promote M1 macrophage polarization in chronic obstructive pulmonary disease. Int Immunopharmacol. 2021;96:107700. doi:10.1016/j.intimp.2021.107700
  • Zhang X, Zhao Y, Zhu X, et al. Active vitamin D regulates macrophage M1/M2 phenotypes via the STAT-1-TREM-1 pathway in diabetic nephropathy. J Cell Physiol. 2019;234(5):6917–6926. doi:10.1002/jcp.27450
  • Molad Y, Pokroy-Shapira E, Carmon V. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding. Innate Immunity. 2013;19(6):623–630. doi:10.1177/1753425913476970
  • Katsel P, Haroutunian V. Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old. Dialogues Clin Neurosci. 2019;21(1):7–19. doi:10.31887/DCNS.2019.21.1/vharoutunian
  • Filipello F, Goldsbury C, You S, Locca A, Karch C, Piccio L. Soluble TREM2: innocent bystander or active player in neurological diseases? Neurobiol Dis. 2022;165:105630. doi:10.1016/j.nbd.2022.105630
  • Li R, Qin Q, Yang H, et al. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener. 2022;17(1):40. doi:10.1186/s13024-022-00542-y
  • Durmanova V, Javor J, Parnicka Z, et al. TREM2 coding variants in Slovak Alzheimer’s disease patients. J Integr Neurosci. 2022;21(4):105. doi:10.31083/j.jin2104105
  • Wu Y, Wu M, Ming S, et al. TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following mycobacterium tuberculosis infection. J Clin Invest. 2021;131(17). doi:10.1172/JCI137407
  • NHFPC. 肺结核诊断标准(WS 288—2017) [Diagnosis of tuberculosis WS288-2017]. 新发传染病电子杂志 [Chin J Infect Control]. 2018;17(7):642–652. Chinese. doi:10.3969/j.issn.1671-9638.2018.07.019
  • Macedo Couto R, Ranzani O, Waldman E. Zoonotic tuberculosis in humans: control, surveillance, and the one health approach. Epidemiologic Reviews. 2019;41(1):130–144. doi:10.1093/epirev/mxz002
  • Ngo M, Bartlett S, Bielefeldt-Ohmann H, et al. A blunted GPR183/oxysterol axis during dysglycemia results in delayed recruitment of macrophages to the lung during mycobacterium tuberculosis infection. J Infect Dis. 2022;225(12):2219–2228. doi:10.1093/infdis/jiac102
  • Chandra P, He L, Zimmerman M, et al. Inhibition of fatty acid oxidation promotes macrophage control of mycobacterium tuberculosis. mBio. 2020;11(4). doi:10.1128/mBio.01139-20
  • Laval T, Chaumont L, Demangel C. Not too fat to fight: the emerging role of macrophage fatty acid metabolism in immunity to mycobacterium tuberculosis. Immunol Rev. 2021;301(1):84–97. doi:10.1111/imr.12952
  • Thacker V, Dhar N, Sharma K, Barrile R, Karalis K, McKinney J. Mycobacterium tuberculosisA lung-on-chip model of early infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth. Elife. 2020;9. doi:10.7554/eLife.59961
  • Khan A, Zhang K, Singh V, et al. Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis. Commun. Biol. 2022;5(1):480. doi:10.1038/s42003-022-03387-9
  • Fuchs A, Syrovets T, Haas K, et al. Carboxyl- and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets. Biomaterials. 2016;85:78–87. doi:10.1016/j.biomaterials.2016.01.064
  • Cheng X, Wang X, Nie K, et al. Systematic pan-cancer analysis identifies TREM2 as an immunological and prognostic biomarker. Front Immunol. 2021;12:646523. doi:10.3389/fimmu.2021.646523
  • Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Iimmunol. 2006;177(4):2051–2055. doi:10.4049/jimmunol.177.4.2051
  • Carrasco K, Boufenzer A, Jolly L, et al. TREM-1 multimerization is essential for its activation on monocytes and neutrophils. Cell Mol Immunol. 2019;16(5):460–472. doi:10.1038/s41423-018-0003-5
  • Lin C, Chang T, Lu Y, et al. TREM-2 mediates dendritic cell-induced NO to suppress Th17 activation and ameliorate chronic kidney diseases. J Mol Med. 2022;100(6):917–931. doi:10.1007/s00109-022-02201-7
  • Seno H, Miyoshi H, Brown SL, Geske MJ, Colonna M, Stappenbeck TS. Efficient colonic mucosal wound repair requires Trem2 signaling. Proc Natl Acad Sci USA. 2009;106(1):256–261. doi:10.1073/pnas.0803343106
  • Correale C, Genua M, Vetrano S, et al. Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response. Gastroenterology. 2013;144(2):346–356.e343. doi:10.1053/j.gastro.2012.10.040
  • Turnbull I, Gilfillan S, Cella M, et al. Cutting edge: TREM-2 attenuates macrophage activation. J Iimmunol. 2006;177(6):3520–3524. doi:10.4049/jimmunol.177.6.3520
  • Jaitin DA, Adlung L, Thaiss CA, et al. Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell. 2019;178(3):686–698.e614. doi:10.1016/j.cell.2019.05.054
  • Leyns CEG, Ulrich JD, Finn MB, et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci USA. 2017;114(43):11524–11529. doi:10.1073/pnas.1710311114
  • Chen Q, Zhang K, Jin Y, et al. Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance. American j Respiratory. 2013;188(2):201–212.
  • Dabla A, Liang Y, Rajabalee N, et al. TREM2 promotes immune evasion by mycobacterium tuberculosis in human macrophages. MBio. 2022;13(4):e0145622. doi:10.1128/mbio.01456-22